| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
29,027 |
24,456 |
$7.61M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
40,421 |
33,859 |
$7.40M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,499 |
2,094 |
$1.80M |
| 95811 |
|
2,007 |
1,671 |
$1.35M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,710 |
3,341 |
$1.27M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,122 |
5,548 |
$846K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,296 |
6,119 |
$766K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
11,408 |
10,325 |
$486K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,278 |
6,847 |
$457K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,041 |
1,134 |
$399K |
| 71045 |
Radiologic examination, chest; single view |
7,175 |
6,408 |
$373K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
949 |
866 |
$276K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
436 |
333 |
$193K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,627 |
2,398 |
$192K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
124 |
101 |
$165K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,553 |
3,152 |
$159K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
811 |
747 |
$145K |
| 81514 |
|
459 |
436 |
$110K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,275 |
4,824 |
$109K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,124 |
998 |
$104K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,879 |
1,736 |
$102K |
| 80053 |
Comprehensive metabolic panel |
39,020 |
34,888 |
$97K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
654 |
581 |
$86K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,282 |
5,801 |
$76K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,978 |
1,429 |
$70K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
926 |
878 |
$65K |
| 71046 |
Radiologic examination, chest; 2 views |
1,100 |
1,012 |
$62K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,831 |
1,694 |
$57K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,830 |
1,693 |
$57K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,911 |
1,267 |
$55K |
| 86850 |
|
2,709 |
2,510 |
$54K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,157 |
6,653 |
$49K |
| 86900 |
|
623 |
571 |
$47K |
| 97602 |
|
459 |
251 |
$42K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
34,882 |
31,088 |
$36K |
| 80061 |
Lipid panel |
3,383 |
3,156 |
$34K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,066 |
1,023 |
$32K |
| 85027 |
|
5,963 |
5,430 |
$28K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
2,951 |
2,426 |
$27K |
| 36415 |
Collection of venous blood by venipuncture |
40,143 |
34,430 |
$27K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,750 |
1,632 |
$27K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,333 |
1,100 |
$22K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
198 |
193 |
$21K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
146 |
144 |
$19K |
| 88142 |
|
1,026 |
980 |
$18K |
| 86780 |
|
1,606 |
1,527 |
$17K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
720 |
676 |
$15K |
| 87800 |
|
348 |
311 |
$14K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
679 |
644 |
$13K |
| 99233 |
Prolong inpt eval add15 m |
206 |
77 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,524 |
4,017 |
$11K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
12 |
12 |
$10K |
| 95805 |
|
12 |
12 |
$6K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
25 |
25 |
$5K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
120 |
39 |
$5K |
| 82728 |
|
439 |
418 |
$5K |
| 97597 |
|
45 |
24 |
$4K |
| 87340 |
|
470 |
443 |
$4K |
| 86803 |
|
317 |
300 |
$4K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
575 |
509 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
53 |
42 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
25 |
24 |
$3K |
| 82607 |
|
190 |
177 |
$2K |
| 84702 |
|
174 |
102 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,181 |
9,655 |
$2K |
| 93922 |
|
27 |
27 |
$2K |
| 83550 |
|
276 |
263 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
36 |
12 |
$2K |
| 84703 |
|
1,119 |
1,033 |
$2K |
| 86762 |
|
141 |
133 |
$2K |
| 83540 |
|
276 |
263 |
$1K |
| 83525 |
|
170 |
163 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,934 |
1,721 |
$1K |
| 95800 |
|
12 |
12 |
$1K |
| 84439 |
|
156 |
148 |
$1K |
| 82746 |
|
81 |
77 |
$896.70 |
| 87653 |
|
30 |
29 |
$831.63 |
| 87522 |
Neg quan hep c or qual rna |
26 |
24 |
$823.48 |
| A9270 |
Non-covered item or service |
4,407 |
3,478 |
$766.04 |
| 99223 |
Prolong inpt eval add15 m |
12 |
12 |
$752.71 |
| 82105 |
|
52 |
51 |
$751.41 |
| 81001 |
|
19,625 |
17,754 |
$571.49 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
78 |
68 |
$547.11 |
| 87081 |
|
75 |
71 |
$425.95 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
13 |
13 |
$369.20 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,106 |
895 |
$293.27 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
14 |
12 |
$240.11 |
| 80306 |
|
2,912 |
2,624 |
$201.98 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,373 |
3,852 |
$200.08 |
| 87420 |
|
45 |
45 |
$153.01 |
| 83690 |
|
7,595 |
6,932 |
$116.22 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,033 |
894 |
$114.43 |
| 87077 |
|
151 |
136 |
$105.04 |
| 87186 |
|
117 |
104 |
$103.80 |
| 85652 |
|
43 |
24 |
$97.38 |
| 84484 |
|
4,729 |
3,972 |
$62.75 |
| 81025 |
|
2,715 |
2,476 |
$49.05 |
| 81002 |
|
313 |
239 |
$19.64 |
| 90686 |
|
15 |
12 |
$15.68 |
| 85610 |
|
917 |
797 |
$8.71 |
| 83880 |
|
515 |
457 |
$5.33 |
| 83735 |
|
2,920 |
2,602 |
$1.26 |
| 82948 |
|
434 |
338 |
$0.83 |
| 86901 |
|
624 |
572 |
$0.00 |
| 83605 |
|
952 |
791 |
$0.00 |
| 85379 |
|
123 |
114 |
$0.00 |
| 82803 |
|
115 |
99 |
$0.00 |
| 85730 |
|
56 |
51 |
$0.00 |
| 87040 |
|
62 |
29 |
$0.00 |
| 74018 |
|
31 |
28 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
31 |
26 |
$0.00 |